Algernon Announces First Patient Dosed in Phase 2 IPF and Chronic Cough Human Trial of Ifenprodil

    NEXT STORY
    AXIM® Biotechnologies Applies for FDA Emergency Use Approval (EUA) for High Throughput, Patent-Pending Neutralizing Antibody Diagnostic Test for COVID-19
    PREV STORY
    Bellerophon Provides Clinical Program Update and Reports Second Quarter 2020 Financial Results
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Translate Bio Announces First Quarter 2021 Financial Results and Provides Corporate Update

    author_avatar
    NASDAQ Market News

    Changes to the Roche Corporate Executive Committee

    Basel, 10 December 2018 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that ...

    author_avatar
    NASDAQ Market News

    Cocrystal Pharma Commences Patient Enrollment for Hong Kong Phase 2a Study of CC-31244 for Ultra-Short Treatment of Hepatitis C Virus

    author_avatar
    NASDAQ Market News